GPBAR1 and Other metabolic disease: The recognition of bile acids as important signaling molecules that orchestrate metabolic homeostasis through specialized receptors (FXR and TGR5) has stimulated active research to determine their relevance to the pathogenesis of, and therapeutic potential for the management of, metabolic disorders.